ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,296Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 315

$988K Total Retail Price of All Prescriptions

Rank: 12 out of 315

550 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Hawaii
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

8% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 11,682 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Hawaii
SIMVASTATIN 615 570 1 1
LEVOTHYROXINE SODIUM 514 492 2 6
ATORVASTATIN CALCIUM 482 477 3 5
METFORMIN HCL ER 464 431 4 33
LISINOPRIL 441 416 5 3
LOSARTAN POTASSIUM 322 312 6 4
AMLODIPINE BESYLATE 282 268 7 2
LOVASTATIN 260 251 8 8
GLIMEPIRIDE 258 238 9 32
METOPROLOL SUCCINATE 258 236 9 13
AMLODIPINE BESYLATE-BENAZEPRIL 244 242 11 26
OMEPRAZOLE 231 225 12 9
METFORMIN HCL 212 211 13 7
TAMSULOSIN HCL 161 161 14 21
FUROSEMIDE 160 149 15 15
LOSARTAN-HYDROCHLOROTHIAZIDE 159 158 16 17
HYDROCODONE-ACETAMINOPHEN 155 144 S3 17 19
HYDROCHLOROTHIAZIDE 154 154 18 16
CELEBREX 149 149 19 34
EXFORGE 146 146 20 107
PRAVASTATIN SODIUM 144 124 21 10
LANTUS SOLOSTAR 141 122 22 69
ALLOPURINOL 140 138 23 14
PEN NEEDLE 134 109 24 91
DONEPEZIL HCL 131 131 25 28
METOPROLOL TARTRATE 119 119 26 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 105 105 27 50
SYNTHROID 105 103 27 51
LIPITOR 97 97 29 44
ZOLPIDEM TARTRATE 97 96 29 29
WARFARIN SODIUM 92 92 31 20
HUMALOG MIX 75-25 90 81 32 205
AZITHROMYCIN 90 83 32 39
BYSTOLIC 84 77 34 73
PANTOPRAZOLE SODIUM 82 82 35 35
PREDNISONE 82 71 35 41
COREG CR 81 81 37 131
NEXIUM 80 68 38 54
NAMENDA 79 79 39 38
DIOVAN 77 66 40 27
ALENDRONATE SODIUM 77 77 40 12
TRAMADOL HCL 70 70 42 59
CLOPIDOGREL 69 69 43 25
INSULIN SYRINGE 68 67 44 79
ADVAIR DISKUS 66 66 45 46
PLAVIX 64 59 46 40
LYRICA 63 62 47 126
SPIRIVA 60 60 48 74
GLIPIZIDE ER 59 58 49 55
DIOVAN HCT 58 58 50 56
HUMALOG 58 54 50 219
CARVEDILOL 55 55 52 22
DILTIAZEM 24HR ER 54 54 53 90
AVODART 53 53 54 113
JANUVIA 51 51 55 31
POTASSIUM CHLORIDE 50 50 56 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.